Model mice for BCR/ABL-positive leukemias

Blood Cells, Molecules, and Diseases

Volumn 27, Issue 1, 2001, Pages 265-278

  Honda, Hiroaki ^a   Hirai, Hisamaru ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; PROTEIN P53; PROTEIN TYROSINE KINASE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENICITY; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; FEMALE; GENOTYPE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTO ONCOGENE; TRANSGENIC MOUSE; TUMOR SUPPRESSOR GENE;

ANIMALIA; MUS MUSCULUS;

EID: 0035051038     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1006/bcmd.2000.0374     Document Type: Article

References (43)

1. Chronic myelogenous leukemia: Recent advances
2. Molecular pathogenesis of Ph-positive leukemias
3. A new consistent chromosomal abnormality in chronic myelogenous leukemia identified by quinacrine fluorescence and Giemsa staining
4. A minute chromosome in human chronic granulocytic leukemia
5. Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22
6. A novel c-abl protein product in Philadelphia-positive acute lymphoblastic leukaemia
7. A novel abl protein expressed in Philadelphia chromosome-positive acute lymphoblastic leukemia
8. Novel chimaeric protein expressed in Philadelphia-positive acute lymphoblastic leukaemia
9. Unique fusion of bcr and c-abl genes in Philadelphia chromosome positive acute lymphoblastic leukemia
10. Unique forms of the abl tyrosine kinase distinguish Ph1-positive CML from Ph1-positive ALL
11. An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity
12. Chromosome abnormalities in malignant hematologic diseases
13. Human p53 gene localized to short arm of chromosome 17
14. Alterations in the p53 gene and the clonal evolution of the blast crisis of chronic myelocytic leukemia
15. Rearrangements in the p53 gene in Philadelphia chromosome positive chronic myelogenous leukemia
16. p53 in chronic myelogenous leukemia in acute phase
17. Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome
18. bcr-abl, the hallmark of chronic myeloid leukaemia in man, induces multiple haemapoietic neoplasms in mice
19. Induction of a chronic myelogenous leukemia-like syndrome in mice with v-abl and BCR/ABL
20. Normal and leukemic SCID-repopulating cells (SRC) coexist in the bone marrow and peripheral blood from CML patients in chronic phase, whereas leukemic SRC are detected in blast crisis
21. High level engraftment of NOD/SCID mice by primitive normal and leukemic hematopoietic cells from patients with chronic myeloid leukemia in chronic phase
22. Animal models for BCR/ABL-induced leukemias
23. Cloning and characterization of mouse tec promoter
24. Identification of PU.1 and Sp1 as essential transcriptional factors for the promoter activity of mouse tec gene
25. A novel protein-tyrosine kinase, tec, is preferentially expressed in liver
26. Enhanced proliferative potential in culture of cells from p53-deficient mice
27. A novel ES cell line, TT2, with high germline-differentiating potency
28. Mutation, loss of heterozygosity, and recombination of the p53 gene in mouse forestomach tumors induced by 2-amino-3,4-dimethylimidazo[4,5-f]quinoline
29. Human BCR/ABL gene has a lethal effect on embryogenesis
30. A bcr-v-ablmed oncogene induces lymphomas in transgenic mice
31. bcr/abl by metallothionein promoter induced T-cell leukemia in transgenic mice
32. BCR/ABL p210 and p190 cause distinct leukemia in transgenic mice
33. A possible correlation between the type of bcr/abl hybrid messenger RNA and platelet count in Philadelphia-positive chronic myelogenous leukemia
34. Chronic myeloid leukemia of thrombocythemic onset: A CML subtype with distinct hematological and molecular features?
35. Hematologic disease induced in BALB/c mice by a bcr-abl retrovirus is influenced by the infection conditions
36. ABL oncogenes directly stimulate two distinct target cells in bone marrow from 5-fluorouracil-treated mice
37. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumors
38. Tumor spectrum analysis in p53-mutant mice
39. Genetic background alters the spectrum of tumors that develop in p53-deficient mice
40. Increased mutation rate precedes leukemic transformation in p190Bcr/abl transgenic mice
41. Blast crisis in a murine model of chronic myelogenous leukemia
42. Efficient transplantation of BCR-ABL-induced chronic myelogenous leukemia-like syndrome in mice
43. Efficient and rapid induction of a chronic myelogenous leukemia-like myeloproliferative disease in mice receiving p210bcr/abl-transduced bone marrow